Repligen traded at $166.52 this Friday July 1st, increasing $4.12 or 2.54 percent since the previous trading session. Looking back, over the last four weeks, Repligen gained 3.39 percent. Over the last 12 months, its price fell by 17.52 percent. Looking ahead, we forecast Repligen to be priced at 162.01 by the end of this quarter and at 149.19 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 119.21 0.44 0.37% -19.90%
Align Technology 247.34 10.67 4.51% -60.37%
BioMarin Pharmaceutical 84.98 2.11 2.55% -0.57%
Bristol-Myers Squibb 76.84 -0.16 -0.21% 14.77%
Bruker 63.54 0.78 1.24% -18.08%
Charles River Laboratories 218.83 4.86 2.27% -41.52%
Catalent 107.02 -0.27 -0.25% -3.69%
Danaher 258.05 4.53 1.79% -5.83%
Exact Sciences 41.13 1.74 4.42% -66.51%
Standard Biotools Inc 1.59 -0.01 -0.63% -72.77%
General Electric 63.54 -0.13 -0.20% -40.55%
Genesis Healthcare 0.10 0 0% -67.08%
Henry Schein 77.11 0.37 0.48% 1.50%
Illumina 191.04 6.68 3.62% -59.76%
IQVIA Holdings Inc 215.05 -1.94 -0.89% -13.69%
Mettler Toledo International 1,161.85 13.08 1.14% -17.08%
Myriad Genetics 18.63 0.46 2.53% -40.48%
NanoString Technologies 13.15 0.45 3.54% -79.00%
OraSure Technologies 2.72 0.01 0.37% -73.36%
Pacific Biosciences Of California 4.47 0.05 1.13% -86.65%
Patterson Companies 30.59 0.29 0.96% 0.66%
Pfizer 52.31 -0.12 -0.23% 31.66%
PerkinElmer 144.07 1.85 1.30% -7.39%
Peregrine Pharmaceuticals 15.33 0.07 0.46% -41.38%
Repligen 166.52 4.12 2.54% -17.52%
Bio Techne 353.18 6.54 1.89% -21.44%
Thermo Fisher Scientific 548.27 4.99 0.92% 6.81%
Waters 336.89 5.91 1.79% -5.23%
West Pharmaceutical Services 307.74 5.37 1.78% -15.86%
Dentsply International 36.20 0.47 1.32% -43.34%

Indexes Price Day Year
USND 11128 99.11 0.90% -23.99%
US2000 1728 19.77 1.16% -25.07%
US400 2296 26.97 1.19% -15.27%

Repligen
Repligen Corporation is a life sciences company that develops and commercializes bioprocessing technologies and systems that rises flexibility in the process of manufacturing biological drugs. The Company's bioprocessing business consist of four franchises, Filtration; Chromatography; Process Analytics; and Proteins. The Filtration products are used in process development and process scale (clinical and commercial) production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all mAb-based drugs on the market.